D. Ascheim

发表

Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification.

A. Boyle, M. Russo, D. Ascheim, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Deepak L. Bhatt, Jane A. Linderbaum, J. Ornato, 2013, Circulation.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Jane A. Linderbaum, J. Ornato, M. Chung, 2013, Journal of the American College of Cardiology.

Thyroid hormone and heart failure

D. Ascheim, U. Schmidt-Ott, 2006, Current heart failure reports.

Long-term use of a left ventricular assist device for end-stage heart failure.

M C Oz, J T Watson, P A Shapiro, 2001, The New England journal of medicine.

181: Early Neurological Adverse Events (NAE) after Pulsatile VAD Implantation in 455 Patients: Incidence, Severity and Outcome

M. Acker, V. Jeevanandam, M. Camacho, 2009 .

Design Challenges for Clinical Trials in Mechanical Circulatory Support

A. Moskowitz, D. Ascheim, A. Gelijns, 2012 .

Progress versus precision: challenges in clinical trial design for left ventricular assist devices.

A. Moskowitz, D. Ascheim, A. Gelijns, 2006, The Annals of thoracic surgery.

The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure.

J T Watson, P A Shapiro, A J Moskowitz, 1999, The Annals of thoracic surgery.

Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices

Doris A Taylor, N. Smedira, P. O'Gara, 2014, Circulation.

Prospective, Multicenter Study of Ventricular Assist Device Infections

Francis D. Pagani, Alan J. Moskowitz, Annetine C. Gelijns, 2013, Circulation.

The cost of medical management in advanced heart failure during the final two years of life.

D. Renlund, A. Moskowitz, M. Oz, 2008, Journal of cardiac failure.

Nurse management of hypertension in rural western Kenya: implementation research to optimize delivery.

V. Fuster, S. Kimaiyo, R. Vedanthan, 2014, Annals of global health.

254: Early Infections after MCSD Implant in 455 Patients: Incidence, Location and Outcome

Robert L. Kormos, Deborah D. Ascheim, James K. Kirklin, 2009 .

Weighting composite endpoints in clinical trials: essential evidence for the heart team.

Joel Huber, E. Blackstone, T. Ferguson, 2012, The Annals of thoracic surgery.

Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.

T. Vassiliades, S. Hoff, G. Weisz, 2013, Journal of the American College of Cardiology.

Challenges in Conducting Implantable Device Trials

A. Moskowitz, D. Ascheim, A. Gelijns, 2006 .

Chapter 23 – What Interventions Are Effective for Managing Dyspnea in Heart Failure?

D. Ascheim, N. Goldstein, 2013 .

Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.

A. Moskowitz, M. Russo, M. Argenziano, 2009, The Annals of thoracic surgery.

Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.

Mohammad R. Ostovaneh, J. Lima, T. Henry, 2020, European heart journal.

ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design

J. Lima, T. Henry, A. DeMaria, 2017, Cell transplantation.

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

R. Finkel, A. Nicorici, F. Muntoni, 2022, The Lancet.

Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial

Mohammad R. Ostovaneh, J. Lima, E. Marbán, 2019, Neurology.

Allogeneic Cardiosphere-derived Cells for the Treatment of Heart Failure with Reduced Ejection Fraction: Results of the Dilated cardiomYopathy iNtervention with Allogeneic Myocardially-regeneratIve Cells (DYNAMIC) trial.

J. Lima, T. Henry, E. Marbán, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state.

K. Hryniewicz, D. Ascheim, 2002, Thyroid : official journal of the American Thyroid Association.

Innovation with experience using implantable left ventricular assist devices.

D. Ascheim, A. Gelijns, E. Rose, 2009, Circulation. Heart failure.

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel

K. Kinnett, L. Cripe, C. Spurney, 2021, Open Heart.

Vasodepressor Syncope Due to Subclinical Myocardial Ischemia

S. Markowitz, B. Lerman, K. Stein, 1997, Journal of cardiovascular electrophysiology.

Innovative clinical trial design in cardiac surgery.

M. Acker, A. Iribarne, D. Ascheim, 2011, Seminars in thoracic and cardiovascular surgery.

5 Risk for Bleeding after MCSD Implant: An Analysis of 2358 Patients in INTERMACS

M. Jessup, D. Ascheim, R. Kormos, 2011 .

Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study

Dennis O. Dixon, Carrie A. Wood, K. Furie, 2017, The Journal of thoracic and cardiovascular surgery.

TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial).

D. Berman, J. Lima, T. Henry, 2016, Journal of the American College of Cardiology.

Randomized trials in surgery.

A. Moskowitz, K. Kent, D. Ascheim, 2009, Surgery.

Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary : A Report of the American College of Cardiology 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:

Jane A. Linderbaum, J. Ornato, H. Krumholz, 2013 .

Abstract 12251: Enrollment Challenges in Cardiovascular Surgical Trials: Experience of the Cardiothoracic Surgical Trials Network

T. Gardner, A. Gillinov, R. Michler, 2011 .

Prospective, Multicenter Study of Ventricular Assist Device Infections Heart

F. Lowy, A. Moskowitz, M. Slaughter, 2013 .

Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.

M. Russo, M. Argenziano, D. Ascheim, 2009, The Journal of thoracic and cardiovascular surgery.

Harlan M Krumholz, Joseph P Ornato, Faha, 2013, Circulation.

Surgical treatment of moderate ischemic mitral regurgitation.

M. Acker, A. Moskowitz, P. O'Gara, 2014, The New England journal of medicine.

Blood transfusion and infection after cardiac surgery.

M. Acker, A. Moskowitz, P. O'Gara, 2013, The Annals of thoracic surgery.

Surgical ablation of atrial fibrillation during mitral-valve surgery.

N. Geller, M. Mack, M. Acker, 2015, The New England journal of medicine.

Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network.

Denis Bouchard, Eugene H Blackstone, Nancy L Geller, 2011, The Journal of thoracic and cardiovascular surgery.

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa

Harlan M Krumholz, Joseph P Ornato, Laura Mauri, 2016, Journal of the American College of Cardiology.

2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Jane A. Linderbaum, J. Ornato, M. Chung, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Management practices and major infections after cardiac surgery.

N. Geller, M. Acker, A. Moskowitz, 2014, Journal of the American College of Cardiology.

The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database.

M. Oz, M. Russo, Mauricio J. Garrido, 2007, The Journal of thoracic and cardiovascular surgery.

Combining Stem Cell Therapy for Advanced Heart Failure and Ventricular Assist Devices: A Review

T. Henry, D. Ramzy, F. Arabía, 2018, ASAIO journal.

Infection after implantation of pulsatile mechanical circulatory support devices.

Robert L Kormos, William L Holman, M. Camacho, 2010, The Journal of thoracic and cardiovascular surgery.

Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database

Yoshifumi Naka, M. Oz, D. Mancini, 2006, Circulation.

Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)

Leslie W. Miller, Deborah D. Ascheim, D. Renlund, 2004, Circulation.

End-stage heart failure: which options?

D. Ascheim, Y. Naka, M. Deng, 2002 .

Adjunctive Therapies with LVADs

Y. Woo, D. Ascheim, A. Gelijns, 2016 .

Adjunctive Therapies with LVADs: Combining Biological and Mechanical Regenerative Therapies

Y. Woo, D. Ascheim, A. Gelijns, 2016 .

Assessing technological change in cardiothoracic surgery.

A. Moskowitz, A. Gelijns, M. Russo, 2009, Seminars in thoracic and cardiovascular surgery.

Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial

Mohammad R. Ostovaneh, J. Lima, T. Henry, 2021, Open Heart.

Usability and feasibility of a tablet-based Decision-Support and Integrated Record-keeping (DESIRE) tool in the nurse management of hypertension in rural western Kenya

Martin C. Were, Deborah D. Ascheim, Rajesh Vedanthan, 2015, Int. J. Medical Informatics.

Pacemaker‐Mediated Programmable Hypertension Control Therapy

P. Neužil, J. Petrů, D. Burkhoff, 2017, Journal of the American Heart Association.

Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Timothy J Gardner, Francois Dagenais, Emilia Bagiella, 2014, The New England journal of medicine.

Pain and Functional Status in Patients With Ventricular Assist Devices.

J. Kirkpatrick, M. Slaughter, E. Bagiella, 2016, Journal of Pain and Symptom Management.

Chapter 57 – What Is the Clinical Course of Advanced Heart Failure and How Do Implanted Cardiac Devices Alter This Course?

D. Ascheim, N. Goldstein, 2013 .

The Relationship Between Psychological Symptoms and Ventricular Assist Device Implantation.

J. Kirkpatrick, M. Slaughter, E. Bagiella, 2017, Journal of pain and symptom management.

Post–Heart Transplant Survival Is Inferior at Low-Volume Centers Across All Risk Strata

M. Russo, A. Iribarne, D. Ascheim, 2010, Circulation.

Asymmetric versus symmetric tethering patterns in ischemic mitral regurgitation: geometric differences from three-dimensional transesophageal echocardiography.

J. Hung, J. Mathew, M. C. Nunes, 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network.

P. O'Gara, J. Alexander, R. Michler, 2012, The Journal of thoracic and cardiovascular surgery.

Clinical Investigations The Cost of Medical Management in Advanced Heart Failure During the Final Two Years of Life

D. Renlund, A. Moskowitz, M. Oz, 2008 .

Changing the research landscape: the New York City Clinical Data Research Network

Rainu Kaushal, George Hripcsak, Arthur L. Caplan, 2014, J. Am. Medical Informatics Assoc..

Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty

R. Levine, M. Mack, P. O'Gara, 2016, Circulation.

Impact of Socioeconomic Status Measures on Hospital Profiling in New York City

A. Moskowitz, A. Blum, D. Ascheim, 2014, Circulation. Cardiovascular quality and outcomes.

The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database.

M. Oz, M. Russo, Mauricio J. Garrido, 2007, The Journal of thoracic and cardiovascular surgery.

Thyroid hormone therapy in cardiovascular disease.

I. Klein, J. Klemperer, K. Hryniewicz, 1996, Progress in cardiovascular diseases.

CARDIOTHORACIC SURGICAL EDUCATION AND

N. Geller, E. Blackstone, M. Russo, 2011 .

Jane A. Linderbaum, C. Tracy, M. Radford, 2016, Circulation.

Blood transfusion and infection after cardiac surgery.

M. Acker, A. Moskowitz, P. O'Gara, 2013, The Annals of thoracic surgery.

Jane A. Linderbaum, C. Tracy, M. Radford, 2016, Journal of the American College of Cardiology.

DYNAMICS OF DEVICE INNOVATION: IMPLICATIONS FOR ASSESSING VALUE

L. Brown, D. Ascheim, A. Gelijns, 2013, International Journal of Technology Assessment in Health Care.